Ingrid Gafanhão

Equity Research Analyst, Healthcare • Bryan, Garnier & Co.

Ingrid Gafanhão is a senior Equity Research Analyst with six years of experience in providing investment ideas to institutional investors. Ingrid specializes in healthcare and is responsible for closely following key European biotechs leading innovation in the cell and gene therapy spaces. Working for key European investment banks that focus on small/mid-sized companies, Ingrid developed an extensive understanding of the factors that drive value in healthcare companies. Ingrid has a bachelor’s degree in biology from Universidad Estadual de Campinas (Brazil) and a master’s degree in Science-Based Business from Leiden University (The Netherlands). 


Also speaking

Anthony Davies

Founder & Chief Executive Officer • Dark Horse Consulting Group

Kate Fynes

CMC Translation Consultant • eXmoor Pharma

Åse Rosenqvist

Nordic Business Unit Lead Cell Therapy • Janssen

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.